Table: begin end state 1 18 cytoplasmic 19 38 transmembrane 39 43 non-cytoplasmic 44 63 transmembrane 64 90 cytoplasmic 91 119 transmembrane 120 124 non-cytoplasmic 125 143 transmembrane 144 154 cytoplasmic 155 177 transmembrane 178 199 non-cytoplasmic 200 223 transmembrane 224 242 cytoplasmic 243 263 transmembrane 264 276 non-cytoplasmic 277 302 transmembrane 303 332 cytoplasmic 333 354 transmembrane 355 359 non-cytoplasmic 360 382 transmembrane 383 402 cytoplasmic 403 425 transmembrane 426 430 non-cytoplasmic 431 449 transmembrane 450 469 cytoplasmic
Input: >GFF344 MQQQEKGLKRGLSARHIRFMALGSAIGTGLFYGSASAIQMAGPAVLLAYLIGGAAVFMVM RALGEMAVHNPVAGSFGQYASTYLGPMAGFILGWTYAFEMIIVCLADVTAFGIYMGFWFP DVARWVWVLGIVLLIGGLNLCNVKVFGEMEFWLSLLKVGAIVAMILGGFGIMLFGIHSAG ETQASGLSNLWAHGGFMPNGIGGLIASFAVVMFAFGGIEIIGITAGEAKDPQRVIPKAIN AVPLRILLFYVLTLFVLMAIYPWPQIGSQGSPFVQIFSNLGIGSAATILNIVVISAAVSA INSDIFGAGRMMYGLAQQGQAPKGFAQLSKQGVPWMTVVVMGAALLGGVVLNYLIPENVF LVIASIATFATVWVWLMILFTQVAMRRSMTKEQVAELKFPVPFWPYAPAAAIVFMLFVFG VLGYFPDTQAALLVGAVWIVLLVVAYLLWVKPSAGQAAKVHYDAALSHR
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server